Discontinued — last reported Q4 '25
Other Financing
Biogen Other Financing decreased by 91.9% to $11.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 769.2%, from $1.30M to $11.30M. Over 4 years (FY 2021 to FY 2025), Other Financing shows an upward trend with a 87.2% CAGR.
Analysis
How to read this metric
An increase in cash outflows here may indicate non-recurring costs related to financing arrangements or adjustments to minority interests, while inflows might represent capital contributions or other unique financing events.
Detailed definition
This metric represents the net cash flows resulting from financing transactions that do not fall into standard categorie...
Peer comparison
Most large-cap companies report this as a catch-all line in the financing section; peers often include items like debt issuance costs or minor equity-related adjustments here.
other_financingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$31.90M | -$2.40M | $0.00 | $4.10M | $7.30M | -$5.50M | -$11.50M | $16.50M | -$16.80M | $2.20M | -$1.90M | $7.30M | -$1.30M | -$6.00M | $0.00 | $1.30M | $0.00 | $141.20M | $138.70M | $11.30M |
| QoQ Change | — | +92.5% | +100.0% | — | +78.0% | -175.3% | -109.1% | +243.5% | -201.8% | +113.1% | -186.4% | +484.2% | -117.8% | -361.5% | +100.0% | — | -100.0% | — | -1.8% | -91.9% |
| YoY Change | — | — | — | — | +122.9% | -129.2% | — | +302.4% | -330.1% | +140.0% | +83.5% | -55.8% | +92.3% | -372.7% | +100.0% | -82.2% | +100.0% | >999% | — | +769.2% |
Other Financing at Other Companies
Frequently Asked Questions
- What is Biogen's other financing?
- Biogen (BIIB) reported other financing of $11.30M in Q1 2026.
- How has Biogen's other financing changed year-over-year?
- Biogen's other financing increased by 769.2% year-over-year, from $1.30M to $11.30M.
- What is the long-term trend for Biogen's other financing?
- Over 4 years (2021 to 2025), Biogen's other financing has grown at a 87.2% compound annual growth rate (CAGR), from -$22.90M to $281.20M.
- What does other financing mean?
- The net cash impact of miscellaneous financing activities that are not classified as debt, dividends, or stock transactions.